Reid, J.

A phase I trial of 17-allylamino-geldanamycin (17AAG) in patients with advanced cancer

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3030-3030

10.1200/jco.2004.22.90140.3030